Bureaucracy stifling studies
A group of researchers whose planned leg ulceration study was hamstrung by a physician recruitment rate of 2% have published the reasons why so many doctors turned them down. The qualitative information, featured in the open access journal BMC Medical Research Methodology, should be of use to those designing trials of their own. Dr. Oliver Herber, from the University of Witten/Herdecke, Germany, worked with a team of researchers to collate the overwhelmingly negative responses received from their potential pool of 1822 medical practices. He said, "Interdisciplinary research studies, especially those between the medical and nursing professions, require careful consideration in the development and tailoring of research designs. To reduce rates of refusal and lack of initial contact, the time, money and effort needed during the planning and recruitment phase of a study must not be underestimated".
Problems identified by Herber and his colleagues include the fact that first contact with most surgeries is through non-medical admin staff who are expert at deflecting all but essential calls. They are especially unlikely to 'put through' non-doctors and may not have a doctor's appreciation for the importance of the study to be carried out. Other factors include GPs' fear of extra work, especially if that work will not be rewarded monetarily, and fear that the results of a study will somehow be used to assess them.
Speaking about the implications of this study for people designing trials, Herber said, "A sustainable and reliable network of teaching surgeries demonstrating interest in research is vital for the successful execution of scientific studies"
Source: BioMed Central
Related
- Doubts cast on credibility of some published clinical trialsThu, 2 Jul 2009, 19:08:07 EDT
- Embarrassing illnesses no bar to information sharingFri, 24 Jul 2009, 0:34:53 EDT
- Race not reported in over 50 percent of randomized clinical trials for cardiovascular diseaseTue, 13 Oct 2009, 14:35:05 EDT
- Patients reveal willingness to trade hands-on medical care for computer consultationsMon, 18 May 2009, 10:43:19 EDT
- Extensive publication bias for Phase I drug trialsWed, 18 Feb 2009, 6:51:38 EST
Other sources
- Why GPs Won't Take Part In Research: Bureaucracy Stifling Studies, Researchers Reportfrom Science DailyMon, 17 Aug 2009, 0:28:20 EDT
- Bureaucracy stifling studiesfrom Science CentricFri, 14 Aug 2009, 9:07:12 EDT
- Bureaucracy And Administrative Roadblocks Impact Research Studiesfrom Scientific BloggingThu, 13 Aug 2009, 23:28:06 EDT
- Bureaucracy stifling studiesfrom PhysorgThu, 13 Aug 2009, 19:56:09 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Exposure to lead, tobacco smoke raises risk of ADHD
- Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
- New study links alcohol in pregnancy to child behavior problems
- New research shows versatility of amniotic fluid stem cells
- New chameleon species discovered in East Africa
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Generating electricity from air flow
- Therapy 32 times more cost effective at increasing happiness than money
- Beyond genomics, biologists and engineers decode the next frontier
- Heart disease found in Egyptian mummies
- Therapy 32 times more cost effective at increasing happiness than money
- Treatment with folic acid, vitamin B12 associated with increased risk of cancer, death
- Full recovery now possible for an 'untreatable' mental illness
- Surface bacteria maintain skin's healthy balance
- UCR plant scientist's research spawns new discoveries showing how crops survive drought
- New evidence that dark chocolate helps ease emotional stress
- African desert rift confirmed as new ocean in the making
- Scientists discover influenza's Achilles heel: Antioxidants
- Nanoparticles used in common household items caused genetic damage in mice
- 1 shot of gene therapy and children with congenital blindness can now see